Skip to content

Yoga Impact in Fibromyalgia, Primary Health Care

Fibromyalgia: Impact on Pain, Quality of Life of a Complementary Therapy on Primary Health Care

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06646796
Enrollment
20
Registered
2024-10-17
Start date
2024-12-01
Completion date
2025-04-30
Last updated
2024-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Keywords

Fibromyalgia, Chronic pain, Yoga, Complementary and alternative medicine

Brief summary

This study aims to evaluate the effectiveness of a complementary therapy using Yoga within the scope of First Health Care in Portugal, in pain control, quality of life and well-being of the patients with Fibromyalgia. It also, pretends to assess the viability and to identify the barriers to this sort of therapy in the context of Primary Health Care.

Detailed description

Fibromyalgia is a chronic and debilitating pain syndrome characterized by widespread and persistent pain, also affecting sleep quality and cognitive function. It is estimated to affect 3.6% of the population; however, since it is a condition that is often underdiagnosed, the actual numbers may be higher. It is also an incurable disease, so treatment is based on symptom management through pharmacological therapy, which is not always effective. Due to the inadequacy of pharmacological therapy, there is a need for complementary therapies, and despite the limited number of studies conducted in this area, some therapies based on meditative movement (notably yoga) are beginning to emerge, with beneficial effects reported on pain management and quality of life in these patients. Therefore, this study aims to investigate the benefits and feasibility of this type of intervention at the Primary Health Care level.

Interventions

OTHERYoga

Yoga with certified teacher, 3 times a week during 3 months.

Sponsors

University of Coimbra
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

In the first phase, the questionnaire will be validated with all patients of the Family Health Unit diagnosed with fibromyalgia who agree to participate. Subsequently, all participants will be asked if they wish to participate in the intervention study, and those who agree will be randomized into either the intervention or control group. The intervention group will engage in Yoga practice with a certified yoga instructor, three times a week for three months. Quality of life scales, a well-being scale, and pain measurement on a numerical scale from 0 to 10 will be applied before and after the intervention, complemented by an open-ended question for qualitative analysis regarding perceived benefits and difficulties.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Users of the Family Health Unit diagnosed with Fibromyalgia; * With cognitive capacity to answer the questionnaire; * With physical capacity to take part in Yoga classes.

Exclusion criteria

* people under 18 years old.

Design outcomes

Primary

MeasureTime frameDescription
Quality of Lifeat the beggining and up to 3 monthsEQ-5D
Painat the beggining and up to 3 monthsVisual scale from 0 to 10 to measure pain
Global perception of changeup to 3 monthsPatient Global Impression of Change scale (portuguese validated version) 1 to 7 (1 is the worst, 7 is the best)

Secondary

MeasureTime frameDescription
Well-beingat the beggining and up to 3 monthsEADS-21
Benefits perceivedup to 3 monthsOpen question answered by the patients trough a written text
Difficulties perceivedup to 3 monthsOpen question answered by the patients trough a written text
Replicability and ease of introducing treatment in the context of the Portuguese national health serviceup to 3 monthsOpen questions and SWOT analysis

Countries

Portugal

Contacts

Primary ContactInês Rosendo Silva, MD PhD
inesrcs@gmail.com(351) 918-4186

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026